A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma

Details for Australian Patent Application No. 2009202925 (hide)

Owner AstraZeneca AB

Inventors Hansson, Johan; Eriksson, Tomas

Agent Freehills

Pub. Number AU-B-2009202925

Parent 2006282121

Filing date 21 July 2009

Wipo publication date 6 August 2009

Acceptance publication date 28 April 2011

International Classifications

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/4375 (2006.01)

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

Event Publications

6 August 2009 Application Open to Public Inspection

  Published as AU-B-2009202925

6 August 2009 Complete Application Filed

28 April 2011 Application Accepted

  Published as AU-B-2009202925

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202926-Truss member transportation system

2009202924-Connection of a structural member to a bond beam